OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Short chain fatty acids, a possible treatment option for autoimmune diseases
Faezeh Golpour, Mehrsa Abbasi-Alaei, Fatemeh Babaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114763-114763
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Gut Microbiota and Autoimmune Diseases: Mechanisms, Treatment, Challenges, and Future Recommendations
Fatemah Sadeghpour Heravi
Current Clinical Microbiology Reports (2024) Vol. 11, Iss. 1, pp. 18-33
Open Access | Times Cited: 22

Interactions of non-starch polysaccharides with the gut microbiota and the effect of non-starch polysaccharides with different structures on the metabolism of the gut microbiota: A review
Yujiao Sun, Jun Yao, Rui Gao, et al.
International Journal of Biological Macromolecules (2025) Vol. 296, pp. 139664-139664
Closed Access | Times Cited: 2

The Role of the Microbiota in the Pathogenesis and Treatment of Atopic Dermatitis—A Literature Review
Martyna Wrześniewska, Julia Wołoszczak, Gabriela Świrkosz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6539-6539
Open Access | Times Cited: 12

The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis
Laura Bărcuţean, Smaranda Maier, Mihai Burai Patrascu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3198-3198
Open Access | Times Cited: 11

Approach to the diagnosis and management of dysbiosis
Kannayiram Alagiakrishnan, Joao Morgadinho, Tyler Halverson
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 11

The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions
Ziwei Lan, Xiangqi Tang, Ming Lu, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26377-e26377
Open Access | Times Cited: 8

Modulation of gut propionate and intestinal mucosal protection by Bifidobacterium longum: Mitigating methotrexate side effects without compromising the efficacy of psoriasis therapy
Manyun Mao, Yan Yuan, Li Rao, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114196-114196
Closed Access | Times Cited: 1

Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches
Eleni S. Vasileiou, Kathryn C. Fitzgerald
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 9, pp. 481-496
Closed Access | Times Cited: 19

Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease
Kavita Kavita, Hari Om, Umesh Chand, et al.
Microbiological Research (2023) Vol. 279, pp. 127550-127550
Closed Access | Times Cited: 16

Interplay between Microbiota and γδ T Cells: Insights into Immune Homeostasis and Neuro-Immune Interactions
Alaa Mohamed, Basel K. al-Ramadi, Maria J. Fernandez‐Cabezudo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1747-1747
Open Access | Times Cited: 6

Understanding How Pre- and Probiotics Affect the Gut Microbiome and Metabolic Health
Patrícia Martins Bock, Andreza Francisco Martins, Beatriz D. Schaan
AJP Endocrinology and Metabolism (2024) Vol. 327, Iss. 1, pp. E89-E102
Closed Access | Times Cited: 6

The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases
Carmela Coccia, Francesco Bonomi, Anna Lo Cricchio, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1760-1760
Open Access | Times Cited: 6

The gut-lung axis in influenza A: the role of gut microbiota in immune balance
Guosen Ou, Huachong Xu, Jialin Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15

Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus
Luis Vitetta, Nick N. Gorgani, Gemma Vitetta, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1307-1307
Open Access | Times Cited: 13

Exploring the significance of microbiota metabolites in rheumatoid arthritis: uncovering their contribution from disease development to biomarker potential
Zi‐feng Lu, Chou‐Yi Hsu, Nada Khairi Younis, et al.
Apmis (2024) Vol. 132, Iss. 6, pp. 382-415
Closed Access | Times Cited: 5

Oral supplementation with propionate is reflected in the serum of healthy individuals
Maximilian Schröder, A. Pasic, Frank Hirche, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access

Amelioration of Central Nervous System Autoimmunity Through FFAR2 Agonism Is Associated With Changes in Gut Microbiota
Bojan Jevtić, Goran Stegnjaić, Suzana Stanisavljević, et al.
Brain and Behavior (2025) Vol. 15, Iss. 3
Open Access

Physicochemical characterization and protective effects of raw and nine-steamed Polygonatum cyrtonema polysaccharides on cyclophosphamide-induced immunosuppression in mice
Weiguang Luo, Xiuwei Li, Chenxi Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 141911-141911
Closed Access

Lipidomic profiling of guava cultivars by UPLC/MS Q-TOF analysis
Xuehua Shao, Lin Ning, Duo Lai, et al.
Scientia Horticulturae (2025) Vol. 342, pp. 114058-114058
Open Access

Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114624-114624
Open Access

Exploring Gut Microbiota in Systemic Lupus Erythematosus: Insights and Biomarker Discovery Potential
Lingyue Jin, Jie Xiao, Yuhong Luo, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access

Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy
Vladimir Rogovskii
Current Cancer Drug Targets (2024) Vol. 24, Iss. 11, pp. 1089-1103
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top